Drug Discovery · Waltham, MA · Founded 2017 · Privately Held (backing)
Developer of microbiome-based health products designed to address age-related inflammatory conditions and improve overall health. Solarea Bio is based in Waltham, MA and was founded in 2017. It was valued at $37 million at its later-stage round in Nov 2025, the last priced event on record. It has raised $37.4 million across 4 recorded rounds; the latest was a $9.9 million early-stage round in Nov 2025.
PMV mark · valuation
$37.0M
Oct 2026
Priced at
its later-stage round
Nov 2025
Total raised
$37.4M
Last round
Early Stage VC
Nov 2025
Cap table — not yet on record
Solarea Bio's share-class structure hasn't surfaced in our sources yet. Cap tables are assembled from certificates of incorporation, round filings, and disclosures as they land.
Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of Solarea Bio with a free account
·The complete investor list: 12 names
·Watch Solarea Bio: the Monday email on marks, rounds and moves